Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | RespireRx Pharmaceuticals |
Description | 4/5/23 – RespireRx Pharmaceuticals Inc. Establishes Research Collaboration with University College CORPORATE Company Overview Board of Directors RespireRx Organization Structure Social Media Guidelines NEUROTRANSMISSION RESOLUTIONRX Cannabinoid Platform |
Keywords | N/A |
WebSite | respirerx.com |
Host IP | 104.238.71.250 |
Location | United States |
Site | Rank |
US$3,126,662
Last updated: 2023-05-10 21:51:06
respirerx.com has Semrush global rank of 3,385,177. respirerx.com has an estimated worth of US$ 3,126,662, based on its estimated Ads revenue. respirerx.com receives approximately 360,769 unique visitors each day. Its web server is located in United States, with IP address 104.238.71.250. According to SiteAdvisor, respirerx.com is safe to visit. |
Purchase/Sale Value | US$3,126,662 |
Daily Ads Revenue | US$2,887 |
Monthly Ads Revenue | US$86,585 |
Yearly Ads Revenue | US$1,039,014 |
Daily Unique Visitors | 24,052 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
respirerx.com. | A | 599 | IP: 104.238.71.250 |
respirerx.com. | NS | 3600 | NS Record: ns55.domaincontrol.com. |
respirerx.com. | NS | 3600 | NS Record: ns56.domaincontrol.com. |
respirerx.com. | MX | 3600 | MX Record: 0 respirerx-com.mail.protection.outlook.com. |
respirerx.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
respirerx.com. | TXT | 3600 | TXT Record: MS=ms77781519 |
CORPORATE Company Overview Board of Directors RespireRx Organization Structure Social Media Guidelines NEUROTRANSMISSION RESOLUTIONRX Cannabinoid Platform Summary Pharmaceutical Cannabinoids Obstructive Sleep Apnea Dronabinol for the Treatment of Obstructive Sleep Apnea Regulatory Process ENDEAVOURRX Neuromodulators Ampakines AMPAkine Platform Summary Lead Compounds Attention Deficit Hyperactivity Disorder (ADHD) Spinal Cord Injury (SCI) GABAkines GABAkines Platform Summary Background Epilepsy Pain PRODUCT PIPELINE INVESTORS Investor Contact SEC Reports News FAQs Presentations CONTACT RespireRx Pharmaceuticals Inc. is a biopharmaceutical company developing innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling. In the News 4/5/23 – RespireRx Pharmaceuticals Inc. Establishes Research Collaboration with University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders April 5, 2023 j3ff1 4/3/23 – RespireRx |
HTTP/1.1 200 OK Accept-Ranges: bytes Age: 78933 Content-Length: 58372 Content-Type: text/html; charset=UTF-8 Date: Tue, 02 Nov 2021 14:50:57 GMT Vary: Accept-Encoding, User-Agent X-Backend: local X-Cache: cached X-Cache-Hit: HIT X-Cacheable: YES:Forced X-Content-Type-Options: nosniff X-Xss-Protection: 1; mode=block |
Domain Name: RESPIRERX.COM Registry Domain ID: 1954966368_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-25T17:04:43Z Creation Date: 2015-08-24T14:34:21Z Registry Expiry Date: 2023-08-24T14:34:21Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS55.DOMAINCONTROL.COM Name Server: NS56.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-06T07:53:44Z <<< |